Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A spanish cooperative group for the treatment of digestive tumors study
- Sastre, J.
- Luisa Maestro, M.
- Gómez-España, A.
- Rivera, F.
- Valladares, M.
- Massuti, B.
- Benavides, M.
- Gallén, M.
- Marcuello, E.
- Abad, A.
- Arrivi, A.
- Fernández-Martos, C.
- González, E.
- Tabernero, J.M.
- Vidaurreta, M.
- Aranda, E.
- Díaz-Rubio, E.
ISSN: 1083-7159, 1549-490X
Ano de publicación: 2012
Volume: 17
Número: 7
Páxinas: 947-955
Tipo: Artigo